Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-010133
Filing Date
2022-04-15
Accepted
2022-04-15 17:12:39
Documents
85
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3098186
2 ex4-1.htm EX-4.1 6855
3 ex10-36a.htm EX-10.36A 81465
4 ex10-39b.htm EX-10.39B 71622
5 ex10-63a.htm EX-10.63A 26039
6 ex10-68.htm EX-10.68 63550
7 ex31-1.htm EX-31.1 17604
8 ex32-1.htm EX-32.1 8872
9 form10-k_001.jpg GRAPHIC 76701
10 form10-k_009.jpg GRAPHIC 6472
11 form10-k_003.jpg GRAPHIC 55084
12 form10-k_004.jpg GRAPHIC 116690
13 form10-k_005.jpg GRAPHIC 158667
14 form10-k_011.jpg GRAPHIC 22055
15 form10-k_012.jpg GRAPHIC 24322
16 ex10-36_001.jpg GRAPHIC 6124
  Complete submission text file 0001493152-22-010133.txt   11978461

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE clcs-20211231.xsd EX-101.SCH 73909
18 XBRL CALCULATION FILE clcs-20211231_cal.xml EX-101.CAL 69467
19 XBRL DEFINITION FILE clcs-20211231_def.xml EX-101.DEF 285186
20 XBRL LABEL FILE clcs-20211231_lab.xml EX-101.LAB 570487
21 XBRL PRESENTATION FILE clcs-20211231_pre.xml EX-101.PRE 409390
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1626871
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55413 | Film No.: 22830591
SIC: 2834 Pharmaceutical Preparations